Effect of Laptm4b Deletion on Hematopoietic Stem and Progenitor Cells Homeostasis in Mice / 中国实验血液学杂志

OBJECTIVE@#To investigate the effect of lysosomal-associated protein transmembrane-4 Beta(Laptm4b) deletion on hematopoietic stem/progenitor cells (HSPCs) homeostasis in mice.@*METHODS@#The hematopoietic system specific Laptm4b-deficient mice were constructed. The number and proportion of HSPCs (LSK, LT, ST, MPP, etc) in Laptm4b-deficient mice were analyzed by flow cytometry. Single SLAM-HSC cell was sorted by flow sorter and cultured in vitro to measure the effect of Laptm4b deletion on the colony forming ability of hematopoietic stem cells (HSCs). The effect of Laptm4b-deficient on the reconstitution ability of HSCs in mice was detected by competitive transplantation experiment of SLAM-HSC cells.@*RESULTS@#Laptm4b deficiency could moderately upregulate the proportion of T cells in the peripheral blood of the mice, but showed no significant effect on the proportion and number of HSPCs. Laptm4b deletion showed no effect on the reconstruction ability of HSCs after competitive transplantation, but it could inhibit the colony formation of HSCs in vitro.@*CONCLUSION@#LAPTM4B may play a role in HSCs under the proliferation stress. Laptm4b-deficient in mice hematopoietic system showed no significant effect on the HSPCs homeostasis maintenance and reconstruction ability.

Functional Changes of High Density Lipoprotein Subclass in Patients With Aortic Dissection / 中国循环杂志

Objective: To observe the functional changes of high density lipoprotein (HDL) subclass in patients with aortic dissection and to explore its clinical significance. Methods: Our research included in 2 groups: Aortic dissection group, n=60 patients and Control group, n=60 healthy subjects from regular physical examination. Blood levels of lipids, HDL subclass of HDL2 and HDL3, macrophage [3H] cholesterol efflux rate, intercellular adhesion molecule-1(ICAM-1), intravascular cellular adhesion molecule-1 (IVCAM-1) and paraoxonase 1 (PON-1) activity were examined and compared between 2 groups. Results: Compared with Control group, Aortic dissection group had reduced HDL2 level (41.15±19.02) mmol/L vs (60.48±22.19) mmol/L, P=0.010 and elevated HDL3 level (58.85±29.97) mmol/L vs (39.52±30.15) mmol/L, P=0.013;decreased macrophage [3H] cholesterol efflux rate (5.79±0.97) ％ vs (11.45±2.15) ％, P<0.01 and decreased PON-l activity (125.62±9.90) μ/ml vs (158.72±13.27) μ/ml, P<0.01; increased expressions of ICAM-1 (33571.85±2529.97) vs (17239.52±4330.15) and IVCAM-1 (442.15±119.02) vs (260.48±92.19) by fluorescence intensity, both P<0.05. Conclusion: Aortic dissection patients showed damaged HDL subclass reverse cholesterol transportation function and anti-oxidative function, both of them were lower than healthy population.

Epidemiological study of the cardiovascular risk factors and clinical medications in patients with cardiovascular diseases in Guangzhou hospitals / 南方医科大学学报

<p><b>OBJECTIVE</b>To study the cardiovascular risk factors and clinical medications in patients with cardiovascular disease in Guangzhou hospitals.</p><p><b>METHODS</b>Cluster sampling and non-random sampling methods were used to analyze the cardiovascular risk factors and clinical medications among the 6691 inpatients with cardiovascular diseases in the department of cardiology of 9 large general hospitals in Guangzhou during 1995-2005.</p><p><b>RESULTS</b>Compared with the data in 1995, the incidences of hypertension, type 2 diabetes, and hypertriglyceridemia increased while hypercholesteremia, elevated low-density lipoprotein, and low high-density lipoprotein levels decreased in 2005. The percentage of patients with level 1 (mild) hypertension was lower while that of patients with level 2 (moderate) hypertension higher in 2005 than in 1995. The percentages of use of angiotensin-converting enzyme inhibitors (ACEI), angiotensin II receptor antagonist (ARB), beta-blockers, diuretics, and anti-platelet drugs (aspirin, clopidogrel), as well as statins lipid-lowering drugs, increased significantly in 2005 as compared with those in 1995.</p><p><b>CONCLUSION</b>The cardiovascular risk factors and clinical medications underwent significant changes in Guangzhou hospitals in the period from 1995 to 2005, and the blood pressure, blood glucose, hypertriglyceridemia of the patients did not appear to be well controlled. The application rate of ACEI, ARB, beta-blockers, diuretics, aspirin, clopidogrel and statins increased rapidly for treatment of cardiovascular diseases, and these drugs have become the first-line drugs.</p>